Advertisement Roche to expand coagulation testing product line in North America - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Roche to expand coagulation testing product line in North America

Roche is set to expand its coagulation testing product by developing a full line of coagulation analyzers for hospital and reference laboratories in North America.

Roche said the newly developed analyzers will be marketed under Roche’s cobas brand and will include three platforms which will address a range of customer needs, from low-volume testing to the high-throughput demands of commercial laboratories, along with a complete menu of coagulation assays.

Roche Diagnostics and Diagnostica Stago will receive separate paths in laboratory coagulation in territories where Roche distributes the Stago line of lab coagulation analyzers.